Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

6 July 2010

Study says normal adult blood can generate pluripotent stem cells

In findings likely to make it easier and faster for stem cell biologists to generate patient-specific embryonic-like stem cells, researchers at Children's Hospital Boston have reprogrammed adult blood cells into induced pluripotent stem (iPS) cells.
6 July 2010

NEWS: Intercell vaccine patch fails Phase II clinical trial

Intercell's investigational vaccine enhancement patch system for avian H5N1 influenza has failed a Phase II study. The company is working under a contract with Human and Health services (HHS) to develop a dose-sparing approach with potential for a single dose immunization combining a H5N1 vaccine with Intercell's LT adjuvant patch.

[adsense:336x280:8701650588]
6 July 2010

Roches new DNA sequencer opens innovation in genomic research

Roche Diagnostics has announced the Asia Pacific launch of the GS Junior System, the company’s new next-generation DNA sequencing platform for life science research. The GS Junior System, developed by 454 Life Sciences, a Roche company, provides an integrated sequencing and bioinformatics solution, all in a size that is no bigger than a typical desktop laser printer.
14 June 2010

The 62nd Indian Pharmaceutical Congress will be held in Manipal

The 62nd Indian Pharmaceutical Congress (IPC), hosted by Indian Hospital Pharmacists’ Association (IHPA), will be held from December 17 to 19, 2010 in Manipal University.
7 June 2010

New standard care of Advanced Melanoma presented in ASCO 2010 annual meeting

June 6, 2010 (Chicago, Illinois) — An experimental therapy for advanced melanoma has been shown to improve overall survival in patients, and is "on the road" to becoming the "new standard of care," said one of its investigators here at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting.
7 June 2010

Karnataka pharma majors bullish over European export prospects

Liquidity crunch and growing uncertainty in the Euro zone have not deterred the Karnataka-based pharma companies from expanding their operations and also patent filing in Europe.

[adsense:336x280:8701650588]
7 June 2010

ICMR to launch task force projects on burden of rotavirus diarrhoea in India

Aiming to understand the potential health benefits of rotavirus vaccination and also to develop a national representative data on rotavirus burden and strains in India, the Indian Council of Medical Research (ICMR) will soon embark on task force projects on burden of rotavirus diarrhoea in India under the Indian Rotavirus Surveillance Network.
10 May 2010

AIDS Control Dept fails to achieve physical target even after utilising 98 % of allocation

Although the department of AIDS Control under the Union health ministry has exhausted its allocation almost completely, it failed to achieve the physical targets set for the last financial year.
10 May 2010

US FDA to review once-weekly treatment for type 2 diabetes Bydureon in October

Amylin Pharmaceuticals, Inc, Eli Lilly and Company and Alkermes, Inc announced that the US Food and Drug Administration (FDA) has classified the Bydureon (exenatide for extended-release injectable suspension) complete response as a Class 2 resubmission and assigned a new Prescription Drug User Fee Act (PDUFA) action date of October 22, 2010.
10 May 2010

Zilver Peripheral Stent Proves Durable

The Zilver PTX (Cook Medical, Bloomington, IN) polymer-free paclitaxel-eluting peripheral stent shows near-perfect two-year durability and safety in a nonrandomized study presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2010 Scientific Sessions in San Diego [1].